Filed
Pursuant to Rule 424(b)(2)
Registration
No. 333-289203
The
information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying
underlying supplement, prospectus supplement and prospectus are not an offer to sell these securities and we are not soliciting an offer
to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject
to Completion, Dated September 1, 2026
Pricing
Supplement dated , 2026
(To
ETF Underlying Supplement dated July 6, 2026,
Prospectus
Supplement dated July 6, 2026, and Prospectus dated July 6, 2026)
Marex
Group Limited
$
Capped Leveraged Buffered Notes Linked to the SPDR® Gold Shares due September 6, 2028
| ► | 2.00x
upside exposure to any increases in the SPDR® Gold Shares (the “Reference
Asset”), subject to a Maximum Return of 41.00% |
| ► | Return
of principal if the price of the Reference Asset does not change or decreases by no more
than 10% |
| ► | 1-to-1
downside exposure to any decrease in the Reference Asset beyond a 10% decline, with up to
90% of the principal at risk. |
| ► | Term:
Approximately 2 years |
| ► | All
payments on the Notes are subject to the credit risk of Marex Group Limited (“Marex”) |
Application
has been made for the Capped Leveraged Buffered Notes (the “Notes”) offered hereunder to be admitted to listing and trading
on the Vienna Multilateral Trading Facility (“Vienna MTF”) of the Vienna Stock Exchange. The Vienna MTF is not a regulated
market as defined by Directive 2014/65/EU (as amended, “MiFID II”). It is, however, a multilateral trading facility (MTF)
for purposes of MiFID II.
Neither
the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of
the Notes or passed upon the accuracy or the adequacy of this document or the accompanying prospectus, prospectus supplement or underlying
supplement. Any representation to the contrary is a criminal offense.
Any
offering of the Notes will be made pursuant to Article 1(4) of Regulation (EU) 2017/1129 (as amended), including as it forms
part of domestic law of the United Kingdom. Accordingly, no prospectus is required to be published in connection with such offering of
the Notes in any member state of the European Economic Area (the "EEA") or the United Kingdom (the "UK"). See page ii
of the accompanying prospectus supplement for further restrictions on offers and sales of the Notes in the EEA and the UK.
Investment
in the Notes involves certain risks. You should refer to “Risk Factors” beginning on page PS-6 of this document, page S-1
of the accompanying prospectus supplement and page S-1 of the accompanying underlying supplement.
The
Estimated Initial Value of the Notes on the Trade Date is expected to be between $960.00 and $990.00 per Note, which will be less than
the price to public. The market value of the Notes at any time will reflect many factors and cannot be predicted with accuracy. See “Summary—Estimated
Initial Value” beginning on page PS-2 and “Risk Factors” beginning on page PS-6 of this document for additional
information.
| |
Price
to Public |
Underwriting
Discount (1) |
Proceeds
to Issuer |
| Per
Note |
$1,000.00 |
|
|
| Total |
|
|
|
| (1) | Marex
Capital Markets Inc. (“MCMI”), an affiliate of ours, will act as the agent for the sale of the Notes. MCMI will purchase
the Notes from us at an underwriting discount of up to $1.00 per $1,000 Principal Amount for distribution to other registered broker-dealers
or will offer the Notes directly to investors. MCMI will use the underwriting discount to pay selling concessions or fees (including
custodial or clearing fees) to other registered broker-dealers. See “Supplemental Plan of Distribution (Conflicts of Interest)”
on page PS-13 of this document. |
The
Notes:
| Are
Not FDIC Insured |
Are
Not Bank Guaranteed |
May Lose
Value |
Marex
Capital Markets
SUMMARY
The
information in this “Summary” section is qualified by the more detailed information set forth in the underlying supplement,
the prospectus supplement and the prospectus. See “General” in this document.
| Issuer: |
Marex Group Limited |
| Principal Amount: |
$1,000 per Note |
| Reference Asset: |
The SPDR® Gold Shares (Bloomberg symbol: GLD) (the “GLD” or the “Reference Asset”) |
| Pricing Date: |
August 31, 2026 |
| Trade Date: |
September 1, 2026 |
| Original Issue Date: |
September 4, 2026 |
| Final Valuation Date: |
August 31, 2028, subject to adjustment as described under “Additional Terms of the Notes - Valuation Dates” in the accompanying underlying supplement. |
| Maturity Date: |
September 6, 2028, subject to adjustment as described under “Additional Terms of the Notes—Interest Payment Dates, Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying underlying supplement. |
| Payment
at Maturity: |
For
each $1,000 Principal Amount of the Notes, you will receive a cash payment on the Maturity Date, calculated as follows: |
| |
If the Reference Return is greater than zero, the lesser
of:
(a) $1,000 + ($1,000 × Reference Return × Upside Participation
Rate); and
(b) $1,000 + ($1,000 × Maximum Return).
If the Reference Return is less than or equal to zero but greater
than or equal to the Buffer Percentage:
$1,000.
If the Reference Return is less than the Buffer Percentage:
$1,000 + [$1,000 × (Reference Return + Buffer Amount)].
In this case, you will lose 1% of the Principal Amount for each
1.00% decrease in the price of the Reference Asset by more than 10%. Accordingly, you may lose up to 90% of the Principal Amount. |
| Upside Participation Rate: |
200.00 (2.00x) |
| Maximum Return: |
41.00% |
| Buffer Percentage: |
-10.00% |
| Buffer Amount: |
10.00% |
| Reference Return: |
The quotient, expressed as a percentage, calculated as follows:
Final Value – Initial Value
Initial Value |
| Initial Value: |
$408.42, which was the Closing Price of the Reference Asset on the Pricing Date, subject to adjustment as described under “Additional Terms of the Notes—Anti-Dilution Adjustments” in the underlying supplement. |
| Final Value: |
The Closing Price of the Reference Asset on the Final Valuation Date. |
| CUSIP / ISIN: |
56653C3J2 / US56653C3J28 |
| Form of Notes: |
Book-Entry |
| Listing: |
Application has been made
for the Notes to be admitted to listing and trading on the Vienna MTF, a multilateral trading facility operated by the Vienna Stock Exchange. |
| Estimated Initial Value: |
The
Estimated Initial Value of the Notes is expected to be less than the price you pay to purchase the Notes. The Estimated Initial Value
does not represent a minimum price at which we or any of our affiliates would be willing to purchase your Notes in the secondary
market, if any, at any time. The Estimated Initial Value will be calculated on the Trade Date and will be set forth in the pricing
supplement to which this document relates. See “Risk Factors — The Estimated Initial Value of the Notes, which will be
determined by us on the Trade Date, is expected to be less than the price to public and may differ from the market value of the Notes
in the secondary market, if any.” |
| Calculation Agent: |
Marex Financial, one of our affiliates |
The
Trade Date and the other dates set forth above are subject to change, and will be set forth in the pricing supplement relating to the
Notes.
GENERAL
This
document relates to an offering of Notes linked to the Reference Asset. The purchaser of a Note will acquire a senior unsecured debt
security of Marex. We reserve the right to withdraw, cancel or modify this offering and to reject orders in whole or in part. Although
the offering of Notes relates to the Reference Asset, you should not construe that fact as a recommendation as to the merits of acquiring
an investment linked to the Reference Asset or any assets held by the Reference Asset or as to the suitability of an investment in the
Notes.
You
should read this document together with the prospectus dated July 6, 2026 (the “prospectus”), the prospectus supplement
dated July 6, 2026 (the “prospectus supplement”), and the ETF Underlying Supplement dated July 6, 2026 (the “underlying
supplement”). If the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus, prospectus
supplement or underlying supplement, the terms described in this document shall control. You should carefully consider, among other things,
the matters set forth in “Risk Factors” beginning on page PS-6 of this document, page S-1 of the prospectus supplement
and page S-1 of the underlying supplement, as the Notes involve risks not associated with conventional debt securities. We urge
you to consult your investment, legal, tax, accounting and other advisors before you invest in the Notes. As used herein, references
to the “Issuer”, “Marex”, “we”, “us” and “our” are to Marex Group Limited.
Certain terms used but not defined herein will have the meanings set forth in the underlying supplement, the prospectus supplement or
the prospectus.
You
may access the underlying supplement, the prospectus supplement and the prospectus on the SEC website www.sec.gov as follows (or if such
address has changed, by reviewing our filing for the relevant date on the SEC website):
4 The
underlying supplement at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295611/d157500d424b2.htm
4 The
prospectus supplement at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295582/d135207d424b2.htm
4 The
prospectus at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295577/d124247d424b3.htm
4 We
are using this document to solicit from you an offer to purchase the Notes. You may revoke your offer to purchase the Notes at any time
prior to the time at which we accept your offer by notifying MCMI. We reserve the right to change the terms of, or reject any offer to
purchase, the Notes prior to their issuance. In the event of any material changes to the terms of the Notes, we will notify you.
PAYMENT
ON THE NOTES
On
the Maturity Date, for each $1,000 Principal Amount of the Notes, we will pay you the Payment at Maturity, which is an amount in cash,
calculated as follows:
If
the Reference Return is greater than zero, the lesser of:
(a) $1,000
+ ($1,000 × Reference Return × Upside Participation Rate); and
(b) $1,000
+ ($1,000 × Maximum Return).
If
the Reference Return is less than or equal to zero but greater than or equal to the Buffer Percentage:
$1,000
(zero return).
If
the Reference Return is less than the Buffer Percentage:
$1,000
+ [$1,000 × (Reference Return + Buffer Amount)].
In
this case, you will lose 1% of the Principal Amount for each 1.00% decrease in the price of the Reference Asset by more than 10%. Accordingly,
you may lose up to 90% of the Principal Amount.
Interest
The
Notes will not pay interest.
INVESTOR
SUITABILITY
The
Notes may be suitable for you if:
| 4 | You
are a retail investor outside the EEA and the UK or an institutional buyer (for restrictions
on offers or sales to retail investors in the EEA and the UK, please see page ii of
the accompanying prospectus supplement). |
| 4 | You
are an investor with the competence (either independently or with the support of a financial
advisor) to assess the suitability of this investment based on your individual circumstances. |
| 4 | You
have the necessary knowledge and/or experience with structured products and are prepared
to accept the corresponding risks. |
| 4 | You
seek an investment with an enhanced return linked to the potential positive performance of
the Reference Asset and you believe that the value of the Reference Asset will increase moderately
over the term of the Notes. |
| 4 | You
are willing to invest in the Notes based on the Maximum Return, which may limit your return
on the Notes. |
| 4 | You
are willing to make an investment that is exposed to the negative Reference Return on a 1:1
basis for each percentage point that the Reference Return is below the Buffer Percentage. |
| 4 | You
are willing to lose up to 90% of the Principal Amount. |
| 4 | You
are willing to forgo the dividends or other distributions paid on the Reference Asset or
the assets held by the Reference Asset. |
| 4 | You
do not seek current income from your investment. |
| 4 | You
are willing to hold the Notes to maturity. |
| 4 | You
do not seek an investment for which there will be an active secondary market. |
| 4 | You
are willing to accept the risk and return profile of the Notes versus a conventional debt
security with a comparable maturity issued by Marex or another issuer with a similar credit
rating. |
| 4 | You
are comfortable with the creditworthiness of Marex, as Issuer of the Notes. |
The
Notes may not be suitable for you if:
| 4 | You
are a retail investor in the EEA or the UK (for restrictions on offers or sales to retail
investors in the EEA and the UK, please see page ii of the accompanying prospectus supplement). |
| 4 | You
are an investor without the competence (either independently or with the support of a financial
advisor) to assess the suitability of this investment based on your individual circumstances. |
| 4 | You
do not have the necessary knowledge and/or experience with structured products and are not
prepared to accept the corresponding risks. |
| 4 | You
believe that the Reference Return will be negative or that the Reference Return will not
be sufficiently positive to provide you with your desired return. |
| 4 | You
are unwilling to invest in the Notes based on the Maximum Return, which may limit your return
at maturity. |
| 4 | You
are unwilling to make an investment that is exposed to the negative Reference Return on a
1:1 basis for each percentage point that the Reference Return is below the Buffer Percentage. |
| 4 | You
seek an investment that provides full return of principal. |
| 4 | You
prefer to receive the dividends or other distributions paid on the Reference Asset or the
assets held by the Reference Asset. |
| 4 | You
seek current income from your investment. |
| 4 | You
are unable or unwilling to hold the Notes to maturity. |
| 4 | You
seek an investment for which there will be an active secondary market. |
| 4 | You
prefer the lower risk, and therefore accept the potentially lower returns, of conventional
debt securities with comparable maturities issued by Marex or another issuer with a similar
credit rating. |
| 4 | You
are not willing or are unable to assume the credit risk associated with Marex, as Issuer
of the Notes. |
RISK
FACTORS
We
urge you to read the section “Risk Factors” beginning on page S-1 of the accompanying prospectus supplement and page S-1
of the accompanying underlying supplement. You should understand the risks of investing in the Notes and should reach an investment decision
only after careful consideration, with your advisors, of the suitability of the Notes in light of your particular financial circumstances
and the information set forth in this document and the accompanying prospectus, prospectus supplement and underlying supplement.
In
addition to the risks discussed below, you should review “Risk Factors” in the accompanying prospectus supplement and underlying
supplement including the explanation of risks relating to the Notes described in the following sections:
4 “—Risks
Related to Note Issuances” in the prospectus supplement;
4 “—General
risks related to a Fund” in the underlying supplement; and
4 “—Additional
risks relating to certain Notes linked to commodity-based Funds” in the underlying supplement.
You
will be subject to significant risks not associated with conventional fixed-rate or floating-rate debt securities.
Risks
Relating to the Structure or Features of the Notes
You
may lose some or a substantial portion of the principal at maturity.
The
Notes do not guarantee full return of principal. You will be exposed to any decrease in the Final Value from the Initial Value beyond
the Buffer Amount on a 1:1 basis. Accordingly, if the Reference Return is less than the Buffer Percentage, your Payment at Maturity will
be less than the Principal Amount of your Notes, and you will lose some or a significant portion (up to 90.00%) of your investment at
maturity.
The
return on the Notes will be limited by the Maximum Return.
You
will not participate in any appreciation in the value of the Reference Asset (as multiplied by the Upside Participation Rate) beyond
the Maximum Return. You will not receive a return on the Notes greater than the Maximum Return.
The
amount payable on the Notes is not linked to the value of the Reference Asset at any time other than on the Final Valuation Date.
The
Final Value will be the Closing Price of the Reference Asset on the Final Valuation Date, subject to postponement for non-trading days
and certain Market Disruption Events. Even if the value of the Reference Asset increases during the term of the Notes other than on the
Final Valuation Date but then decreases on the Final Valuation Date to a value that is less than the Initial Value, the Payment at Maturity
will be less, possibly significantly less, than it would have been had the Payment at Maturity been linked to the value of the Reference
Asset prior to that decrease. Although the actual value of the Reference Asset on the Maturity Date or at other times during the term
of the Notes may be higher than the Final Value, the Payment at Maturity will be based solely on the value of the Reference Asset on
the Final Valuation Date.
The
Notes will not bear interest.
As
a holder of the Notes, you will not receive interest payments.
Risks
Relating to the Reference Asset
Single
commodity prices tend to be more volatile than, and may not correlate with, the prices of commodities generally.
The
Reference Asset holds a single commodity and not diverse basket of commodities or components of a broad-based commodity index. The Reference
Asset’s underlying assets may not correlate to the price of commodities generally and may diverge significantly from the prices
of commodities generally. As a result, the Notes carry greater risk and may be more volatile than notes linked to the prices of more
commodities or a broad-based commodity index.
Gold
prices are characterized by high and unpredictable volatility, which could lead to high and unpredictable volatility in the Reference
Asset.
The
investment objective of the Reference Asset is to reflect the performance of the price of gold bullion, less the Reference Asset’s
expenses. The price of gold is primarily affected by the global demand for and supply of gold. The market for gold bullion is global,
and gold prices are subject to volatile price movements over short periods of time and are affected by numerous factors, including macroeconomic
factors, such as the structure of and confidence in the global monetary system, expectations regarding the future rate of inflation,
the relative strength of, and confidence in, the U.S. dollar (the currency in which the price of gold is usually quoted), interest rates,
gold borrowing and lending rates and global or regional economic, financial, political, regulatory, judicial or other events. Gold prices
may be affected by industry factors, such as industrial and jewelry demand as well as lending, sales and purchases of gold by the official
sector, including central banks and other governmental agencies and multilateral institutions that hold gold. Additionally, gold prices
may be affected by levels of gold production, production costs and short-term changes in supply and demand due to trading activities
in the gold market. From time to time, above-ground inventories of gold may also influence the market. It is not possible to predict
the aggregate effect of all or any combination of these factors. The price of gold has recently been, and may continue to be, extremely
volatile. Consequently, the performance of the Reference Asset and the return on the Notes could be adversely affected.
The
value of the Reference Asset may not fully replicate the price of gold.
The
performance of the Reference Asset may not fully replicate the price of gold due to the fees and expenses charged by the Reference Asset,
restrictions on access to gold or other circumstances. The Reference Asset does not generate any income and as the Reference Asset regularly
sells gold to pay for its ongoing expenses, the amount of gold represented by the Reference Asset has gradually declined over time. The
Reference Asset sells gold to pay expenses on an ongoing basis irrespective of whether the trading price of the Reference Asset rises
or falls in response to changes in the price of gold. The sale of the Reference Asset’s gold to pay expenses at a time of low gold
prices could adversely affect the value of the Reference Asset. Additionally, there is a risk that part or all of the Reference Asset’s
gold could be lost, damaged or stolen due to war, terrorism, theft, natural disaster or otherwise.
There
are risks relating to commodities trading on the London Bullion Market Association.
The
value of the Reference Asset is closely related to the price of gold. Gold is traded on the London Bullion Market Association (the “LBMA”).
The LBMA is a self-regulated association of bullion market participants. Although all market-making members of the LBMA are supervised
by the Bank of England and are required to satisfy a capital adequacy test, the LBMA itself is not a regulated entity. If the LBMA should
cease operations, or if bullion trading should become subject to a value added tax or other tax or any other form of regulation currently
not in place, the role of the LBMA gold prices as a global benchmark for the value of gold may be adversely affected. The LBMA is a principals’
market which operates in a manner more closely analogous to over-the-counter physical commodity markets than regulated futures markets,
and certain features of U.S. futures contracts are not present in the context of LBMA trading. For example, there are no daily price
limits on the LBMA, which would otherwise restrict fluctuations in the prices of commodities trading on the LBMA. In a declining market,
it is possible that prices would continue to decline without limitation within a trading day or over a period of trading days
The
performance of the Reference Asset may not correlate with the performance of its underlying assets as well as the net asset value per
share of the Reference Asset, especially during periods of market volatility.
The
performance of the Reference Asset and that of its underlying assets generally will vary due to, for example, transaction costs, management
fees, certain corporate actions, and timing variances. Moreover, it is also possible that the performance of the Reference Asset may
not fully replicate or may, in certain circumstances, diverge significantly from the performance of its underlying assets. This could
be due to, for example, the Reference Asset holding assets that are not related to the underlying assets, the temporary unavailability
of certain assets in the secondary market, the performance of any derivative instruments held by the Reference Asset, differences in
trading hours between the Reference Asset and the underlying assets, or due to other circumstances. This variation in performance is
called the “tracking error,” and, at times, the tracking error may be significant.
In
addition, because the shares of the Reference Asset are traded on a securities exchange and are subject to market supply and investor
demand, the market price of one share of the Reference Asset may differ from its net asset value (“NAV”) per share; shares
of the Reference Asset may trade at, above, or below its NAV per share.
During
periods of market volatility, certain assets held by the Reference Asset may be unavailable in the secondary market, market participants
may be unable to calculate accurately the NAV per share of the Reference Asset and the liquidity of the Reference Asset may be adversely
affected. This kind of market volatility may also disrupt the ability of market participants to create and redeem shares of the Reference
Asset. Further, market volatility may adversely affect, sometimes materially, the prices at which market participants are willing to
buy and sell shares of the Reference Asset. As a result, under these circumstances, the market value of shares of the Reference Asset
may vary substantially from the NAV per share of the Reference Asset.
For
the foregoing reasons, the performance of the Reference Asset may not match the performance of its underlying assets over the same period.
Because of this variance, the return on the Notes, to the extent dependent on the performance of the Reference Asset, may not be the
same as an investment directly in the securities, commodities, or other assets held by the Reference Asset or the same as a debt security
with a return linked to the performance of such underlying assets.
General
Risk Factors
The
Notes are subject to our credit risk.
Marex
may partially or wholly fail to meet their obligations under the Notes. Investors should therefore take the creditworthiness of Marex
and its subsidiaries into account in their investment decision. Credit risk means the risk of insolvency or illiquidity of an issuer,
i.e. a potential, temporary or final inability to fulfil their interest and repayment obligations on time. An increased insolvency risk
is typical of issuers that have a low creditworthiness. The payment of any amount due on the Notes is subject to the credit risk of Marex.
The Notes are senior unsecured debt obligations of Marex, and are not, either directly or indirectly, an obligation of any third party.
Investors are dependent on Marex’s ability to pay all amounts due on the Notes, and therefore investors are subject to the credit
risk of Marex and to changes in the market’s view of its creditworthiness
The
Notes are not bank deposits and are not insured or guaranteed by the U.S. Federal Deposit Insurance Corporation, the UK Financial Services
Compensation Scheme or any other government or governmental or private agency or deposit protection scheme in any jurisdiction. Investors
are dependent on Marex’s ability to pay all amounts due on the Notes, and therefore investors are subject to Marex’s credit
risk and to changes in the market’s view of Marex’s creditworthiness. The payment of any amount due on the Notes is not guaranteed
by any entity.
The
Notes are not insured against loss by any third parties; you can depend only on our earnings and assets for any payment on the Notes.
The
Notes will be solely our obligations, and no other entity will have any obligation, contingent or otherwise, to make any payments in
respect of the Notes.
The
Estimated Initial Value of the Notes, which will be determined by us on the Trade Date, is expected to be less than the price to public
and may differ from the market value of the Notes in the secondary market, if any.
The
Estimated Initial Value of the Notes will be calculated by us on the Trade Date and is expected to be less than the price to public.
The Estimated Initial Value will reflect our and our affiliates’ internal funding rate, which is the borrowing rate paid to issue
market-linked securities, as well as the mid-market value of the embedded derivatives in the Notes. This internal funding rate is typically
lower than the rate we would use when we issue conventional fixed or floating rate debt securities. As a result of the difference between
our internal funding rate and the rate we would use when we issue conventional fixed or floating rate debt securities, the Estimated
Initial Value of the Notes may be lower if it were based on the prices at which our fixed or floating rate debt securities trade in the
secondary market. In addition, if we were to use the rate we use for our conventional fixed or floating rate debt issuances, we would
expect the economic terms of the Notes to be more favorable to you. We will determine the value of the embedded derivatives in the Notes
by reference to our or our affiliates’ internal pricing models. These pricing models consider certain assumptions and variables,
which can include volatility and interest rates. Different pricing models and assumptions could provide valuations for the Notes that
are different from our Estimated Initial Value. These pricing models rely in part on certain forecasts about future events, which may
prove to be incorrect. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing
to purchase your Notes in the secondary market (if any exists) at any time.
The
price of your Notes in the secondary market, if any, immediately after the Trade Date is expected to be less than the price to public.
The
price to public takes into account certain costs. These costs include our affiliates’ projected hedging profits (which may or may
not be realized) for assuming risks inherent in hedging our obligations under the Notes, the underwriting discount and the costs associated
with structuring and hedging our obligations under the Notes. These costs will be used or retained by us or one of our affiliates, except
for underwriting discounts paid to unaffiliated distributors. If you were to sell your Notes in the secondary market, if any, the price
you would receive for your Notes may be less than the price you paid for them because secondary market prices will not take into account
these costs. The price of your Notes in the secondary market, if any, at any time after issuance will vary based on many factors, including
the value of the Reference Asset and changes in market conditions, and cannot be predicted with accuracy. The Notes are not designed
to be short-term trading instruments, and you should, therefore, be able and willing to hold the Notes to maturity. Any sale of the Notes
prior to maturity could result in a loss to you.
If
we were to repurchase your Notes immediately after the Original Issue Date, the price you receive may be higher than the Estimated Initial
Value of the Notes.
Assuming
that all relevant factors remain constant after the Original Issue Date, the price at which MCMI may initially buy or sell the Notes
in the secondary market, if any, and the value that may initially be used for customer account statements, if any, may exceed the Estimated
Initial Value on the Trade Date for a temporary period expected to be approximately 6 months after the Original Issue Date. This temporary
price difference may exist because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated
cost of hedging our obligations under the Notes and other costs in connection with the Notes that we will no longer expect to incur over
the term of the Notes. We will make such discretionary election and determine this temporary reimbursement period on the basis of a number
of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated
costs which we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we
may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Original Issue Date of the
Notes based on changes in market conditions and other factors that cannot be predicted.
You
will not have any ownership interest in the Reference Asset or any assets held by the Reference Asset.
As
a holder of the Notes, you will not have any ownership interest in the Reference Asset or any assets held by the Reference Asset, such
as rights to vote, dividend payments or other distributions. Because the return on the Notes will not reflect any dividends on the Reference
Asset or any assets held by the Reference Asset, the Notes may underperform an investment in the Reference Asset or the assets held by
the Reference Asset.
The
Notes lack liquidity.
The
Notes are a new issue of securities for which there is no established market. Although we will apply for the Notes to be listed for trading
on the Vienna MTF, we cannot provide you with any assurance regarding whether the Notes will become or remain listed or whether a trading
market for the Notes will develop or as to the liquidity or sustainability of any such market, the ability of holders of the Notes to
sell their Notes or the price at which holders may be able to sell their Notes. The listing application will be subject to approval by
the Vienna Stock Exchange. There can be no assurance that application for listing and admission to trading will be granted or that an
active trading market in the Notes will develop. If such a listing is obtained, we have no obligation to maintain such listing, and we
may delist the Notes at any time. In addition, MCMI is not required to offer to purchase the Notes in the secondary market. Even if a
secondary market were to develop, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers
are not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely to depend on
the price, if any, at which MCMI is willing to buy the Notes.
Potential
conflicts of interest may exist.
Marex
and its affiliates play a variety of roles in connection with the issuance of the Notes, including acting as calculation agent and hedging
our obligations under the Notes. Following the occurrence of certain events – relating to the Issuer, the Issuer's hedging arrangements,
the Reference Asset, taxation, the relevant currency or other matters – outside of the Issuer's control, the calculation agent
may determine in its discretion to take one of the actions available to it in order to deal with the impact of such event on the Notes
or the Issuer or both. These actions may include (i) adjustment to the terms and conditions of the Notes, (ii) substitution
of the Reference Asset and/or (iii) early redemption or exercise of the Notes. In performing these duties, the economic interests
of the calculation agent and other affiliates of ours are potentially adverse to your interests as an investor in the Notes. Any such
discretionary determination by the Issuer or the calculation agent could have a negative impact on the value of the Notes. We will not
have any obligation to consider your interests as a holder of the Notes in taking any action that might adversely affect the value of
your Notes.
Uncertain
tax treatment.
For
a discussion of the U.S. federal income tax consequences of your investment in a Note, please see the discussion under “U.S. Federal
Income Tax Considerations” herein, the discussion under “U.S. Federal Income Tax Considerations” in the accompanying
prospectus supplement and the discussion under “Material Tax Considerations — Material U.S. Federal Income Tax Considerations”
in the accompanying prospectus.
ILLUSTRATIVE
EXAMPLES
The
following table and examples are provided for illustrative purposes only and are hypothetical. They do not purport to be representative
of every possible scenario concerning increases or decreases in the Final Value relative to the Initial Value. We cannot predict the
Closing Price of the Reference Asset at any time during the term of the Notes, including the Final Valuation Date. The assumptions we
have made in connection with the illustrations set forth below may not reflect actual events. You should not take this illustration or
these examples as an indication or assurance of the expected performance of the Reference Asset or the return on your Notes. The numbers
appearing in the table below and following examples have been rounded for ease of analysis.
The
table and examples below illustrate the Payment at Maturity on a $1,000 investment in the Notes for a hypothetical range of Reference
Returns from -100% to +100%. The following results are based solely on the assumptions outlined below. The “Hypothetical Return
on the Notes” as used below is the number, expressed as a percentage, that results from comparing the Payment at Maturity per $1,000
Principal Amount to $1,000. The potential returns described below assume that the Notes are held to maturity. The following table and
examples assume the following:
| Principal
Amount: |
$1,000 |
| Hypothetical
Initial Value: |
$100.00 |
| Maximum
Return: |
41.00% |
| Upside
Participation Rate: |
200.00% |
| Buffer
Percentage: |
-10.00% |
| Buffer
Amount: |
10.00% |
Hypothetical
Final
Value |
Hypothetical
Reference Return |
Hypothetical
Payment at
Maturity |
Hypothetical
Return on
the Notes |
| $200.00 |
100.00% |
$1,410.00 |
41.00% |
| $180.00 |
80.00% |
$1,410.00 |
41.00% |
| $160.00 |
60.00% |
$1,410.00 |
41.00% |
| $140.00 |
40.00% |
$1,410.00 |
41.00% |
| $120.50 |
20.50% |
$1,410.00 |
41.00%(1) |
| $110.00 |
10.00% |
$1,200.00 |
20.00% |
| $105.00 |
5.00% |
$1,100.00
|
10.00% |
| $102.00 |
2.00% |
$1,040.00
|
4.00% |
| $100.00(2) |
0.00% |
$1,000.00 |
0.00% |
| $95.00 |
-5.00% |
$1,000.00 |
0.00% |
| $92.00 |
-8.00% |
$1,000.00 |
0.00% |
| $90.00 |
-10.00%(3) |
$1,000.00 |
0.00% |
| $85.00 |
-15.00% |
$950.00 |
-5.00% |
| $80.00 |
-20.00% |
$900.00 |
-10.00% |
| $60.00 |
-40.00% |
$700.00 |
-30.00% |
| $40.00 |
-60.00% |
$500.00
|
-50.00% |
| $20.00 |
-80.00% |
$300.00
|
-70.00% |
| $0.00 |
-100.00% |
$100.00
|
-90.00% |
| (1) | The
return on the Notes cannot exceed the Maximum Return. |
| (2) | The
hypothetical Initial Value of $100.00 used in these examples has been chosen for illustrative
purposes only. The actual Initial Value of the Reference Asset is set forth on page PS-2
of this document. |
| (3) | This
is the Buffer Percentage. |
The
following examples indicate how the Payment at Maturity would be calculated with respect to a hypothetical $1,000 investment in the Notes
assuming that the Notes are held to maturity.
Example
1: The Reference Return Is 50.00%.
Because
the Reference Return multiplied by the Upside Participation Rate exceeds the Maximum Return, the Payment at Maturity would be $1,410.00
per $1,000 Principal Amount, calculated as follows:
$1,000
+ ($1,000 × Maximum Return)
=
$1,000 + ($1,000 × 41.00%)
=
$1,410.00
Example
1 shows that the return on the Notes will not exceed the Maximum Return, regardless of the extent to which the value of the Reference
Asset increases.
Example
2: The Reference Return Is 2.00%.
Because
the Reference Return multiplied by the Upside Participation Rate does not exceed the Maximum Return, the Payment at Maturity would be
$1,040.00 per $1,000 Principal Amount, calculated as follows:
$1,000
+ ($1,000 × Reference Return × Upside Participation Rate)
=
$1,000 + ($1,000 × 2.00% × 200%)
=
$1,040.00
Example
2 shows that the Notes provide a leveraged return if the Reference Return multiplied by the Upside Participation Rate does not exceed
the Maximum Return.
Example
3: The Reference Return Is -5.00%.
Because
the Reference Return is less than or equal to zero but greater than or equal to the Buffer Percentage, the Payment at Maturity would
be $1,000.00 per $1,000 Principal Amount.
Example
3 shows that the Payment at Maturity will equal the Principal Amount if the Reference Return is less than or equal to zero but greater
than or equal to the Buffer Percentage, although the value of the Reference Asset has decreased moderately.
Example
4: The Reference Return Is -80.00%.
Because
the Reference Return is less than the Buffer Percentage, the Payment at Maturity would be $300.00 per $1,000 Principal Amount, calculated
as follows:
$1,000
+ [$1,000 × (Reference Return + Buffer Amount)]
=
$1,000 + [$1,000 × (-80.00% + 10.00%)]
=
$300.00
Example
4 shows that you are exposed on a 1:1 basis to any decrease in the value of the Reference Asset by more than the Buffer Amount. You
may lose up to 90% of your Principal Amount.
DESCRIPTION
OF THE REFERENCE ASSET
Description
of the GLD
The
GLD seeks to provide investment results that, before fees and expenses, correspond generally to the performance of the price of gold
bullion. Shares of the GLD are listed and trade on the NYSE Arca under the symbol "GLD."
For
more information about the GLD, see "Reference Sponsors and Funds—The SPDR® Gold Shares" beginning
on page S-74 of the accompanying underlying supplement. |
|
Historical
Performance of the Reference Asset
The
following graph sets forth the historical performance of the GLD based on the daily historical closing values from August 31,
2021 through August 31, 2026. We obtained the closing values below from Bloomberg L.P. (“Bloomberg”). We have not
undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from Bloomberg.

|
The
historical values of the Reference Asset should not be taken as an indication of its future performance, and no assurance can be given
as to the Closing Price of the Reference Asset on the Final Valuation Date.
SUPPLEMENTAL
PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)
We
have appointed MCMI, an affiliate of Marex, as the agent for the sale of the Notes. Pursuant to the terms of a distribution agreement,
MCMI will purchase the Notes from Marex at the price to public less the underwriting discount set forth on the cover page of the
pricing supplement to which this document relates, for distribution to other registered broker-dealers or will offer the Notes directly
to investors. MCMI proposes to offer the Notes at the price to public set forth on the cover page of this document. MCMI will use
the underwriting discount to pay selling concessions or fees (including custodial or clearing fees) to other registered broker-dealers.
An
affiliate of Marex has paid or may pay in the future an amount to broker-dealers in connection with the costs of the continuing implementation
of systems to support the Notes. We or one of our affiliates may pay a fee to one or more broker dealers for providing certain services
with respect to this offering, which may reduce the economic terms of the Notes to you.
In
addition, MCMI or another of our affiliates or agents may use the pricing supplement to which this document relates in market-making
transactions after the initial sale of the Notes, but is under no obligation to make a market in the Notes and may discontinue any market-making
activities at any time without notice.
See
“Supplemental Plan of Distribution (Conflicts of Interest)” on page S-61 in the prospectus supplement.
We
expect that delivery of the Notes will be made against payment for the Notes on or about the Original Issue Date set forth on the inside
cover page of this document, which is more than one business day following the Trade Date. Under Rule 15c6-1 under the Securities
Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day, unless the parties to that
trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes more than one business day prior to the Original
Issue Date will be required to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement, and
should consult their own advisors.
U.S.
FEDERAL INCOME TAX CONSIDERATIONS
The
U.S. federal income tax consequences of each holder’s investment in the Notes are uncertain. There are no Treasury Regulations,
published rulings or judicial decisions addressing the treatment for U.S. federal income tax purposes of securities with terms that are
substantially the same as the Notes. By purchasing the Notes, each holder agrees (in the absence of a change in law, an administrative
determination or a judicial ruling to the contrary) to treat each Note as a pre-paid executory contract for U.S. federal income tax purposes.
In the opinion of our counsel, Mayer Brown LLP, it would generally be reasonable to treat the Notes as pre-paid executory contracts in
respect of the Reference Asset for U.S. federal income tax purposes.
In addition, subject to the discussion in the accompanying prospectus supplement regarding section 1260 of the Code, a U.S. Holder should
generally recognize capital gain or loss upon redemption, sale or maturity or other taxable disposition of such holder’s Notes in
an amount equal to the difference between the amount realized at such time and such holder’s tax basis in such Notes. In general,
a U.S. Holder’s tax basis in the Notes will equal the holder’s cost for the Notes. Such gain or loss should generally be long-term
capital gain or loss if a U.S. Holder has held the Notes for more than one year (otherwise such gain or loss should be short-term capital
gain or loss if held for one year or less). The deductibility of capital losses is subject to limitations. U.S. Holders should consult
their tax advisors regarding this risk.
The
U.S. federal income tax consequences of a U.S. Holder’s investment in the Notes are uncertain and the Internal Revenue Service
could assert that the Notes should be taxed in a manner that is different from that described above. Please see the discussion in the
accompanying prospectus supplement under “U.S. Federal Income Tax Considerations” and in particular the discussion under
"U.S. Federal Income Tax Considerations —U.S. Holders — Certain Notes Treated as a Put Option and a Deposit or an Executory
Contract — Certain Notes Treated as Executory Contracts” and the discussion in the accompanying prospectus under “Material
Tax Considerations — Material U.S. Federal Income Tax Considerations”.
Non-U.S.
Holders should review the discussion in the accompanying prospectus supplement under “U.S. Federal Income Tax Considerations —
Non-U.S. Holders” for a discussion of the U.S. federal income tax consequences applicable to Non-U.S. Holders.
A
“dividend equivalent” payment is treated as a dividend from sources within the United States and such payments generally
would be subject to a 30% U.S. withholding tax if paid to a Non-U.S. Holder. Under Treasury Regulations, payments (including deemed payments)
with respect to equity-linked instruments (“ELIs”) that are “specified ELIs” may be treated as dividend equivalents
if such specified ELIs reference an interest in an “underlying security,” which is generally any interest in an entity taxable
as a corporation for U.S. federal income tax purposes if a payment with respect to such interest could give rise to a U.S. source dividend.
However, IRS guidance provides that withholding on dividend equivalent payments will not apply to specified ELIs that are not delta-one
instruments and that are issued before January 1, 2027. We expect that the delta of the Notes will not be one, and therefore, we
expect that Non-U.S. Holders should not be subject to withholding on dividend equivalent payments, if any, under the Notes. However,
it is possible that the Notes could be treated as deemed reissued for U.S. federal income tax purposes upon the occurrence of certain
events affecting the Reference Asset or the Notes, and following such occurrence the Notes could be treated as subject to withholding
on dividend equivalent payments. Non-U.S. Holders that enter, or have entered, into other transactions in respect of the Reference Asset
or the Notes should consult their tax advisors as to the application of the dividend equivalent withholding tax in the context of the
Notes and their other transactions. If any payments are treated as dividend equivalents subject to withholding, we (or an applicable
withholding agent) would be entitled to withhold taxes without being required to pay any additional amounts with respect to amounts so
withheld.
PROSPECTIVE
PURCHASERS OF THE NOTES SHOULD CONSULT THEIR TAX ADVISORS AS TO THE TAX CONSEQUENCES OF THE ABOVE DESCRIBED CHARACTERIZATION OF THE NOTES
AND ANY POSSIBLE ALTERNATIVE CHARACTERIZATIONS OF THE NOTES FOR U.S. FEDERAL INCOME TAX PURPOSES. PROSPECTIVE PURCHASERS OF NOTES SHOULD
CONSULT THEIR TAX ADVISORS AS TO THE FEDERAL, STATE, LOCAL, AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION
OF NOTES.